Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Torti

Showing results (201-210 of 263) with videos related to

Pageof 27
Sort By:
Mediterranean Journal of Hematology and Infectious Diseases|November 7, 2015
Demographical, Viro-Immunological, Clinical and Therapeutical Characteristics of HIV-Infected Patients in an "Epidemiologically Unexplored" Region of Italy (Calabria Region): the CalabrHIV CohortMaria Concetta Postorino, Filippo Luciani, Carmelo Mangano, et al.
AIDS Reviews|November 24, 2005
Antiretroviral therapy in chronic liver disease: focus on HIV/HCV coinfection--statements of the First Italian Consensus WorkshopGiampiero Carosi, Massimo Puoti, Giovanni Antonucci, et al.
Plos One|April 25, 2013
Clinical evaluation of Rega 8: an updated genotypic interpretation system that significantly predicts HIV-therapy responseJurgen Vercauteren, Gertjan Beheydt, Mattia Prosperi, et al.
Open Forum Infectious Diseases|July 28, 2015
Two Distinct Hepatitis C Virus Genotype 1a Clades Have Different Geographical Distribution and Association With Natural Resistance to NS3 Protease InhibitorsAndrea De Luca, Simona Di Giambenedetto, Alessandra Lo Presti, et al.
BMC Infectious Diseases|November 14, 2013
Superinfection with drug-resistant HIV is rare and does not contribute substantially to therapy failure in a large European cohortIstván Bartha, Matthias Assel, Peter M A Sloot, et al.
BMC Evolutionary Biology|March 9, 2017
Implications of hepatitis C virus subtype 1a migration patterns for virus genetic sequencing policies in ItalyLize Cuypers, Bram Vrancken, Lavinia Fabeni, et al.
Communications Medicine|November 19, 2025
Third-generation Cephalosporin resistance in Sub-Saharan Africa: a systematic review and meta-analysisGiacomo Guido, Luisa Frallonardo, Muhammad Asaduzzaman, et al.
Clinical Chemistry and Laboratory Medicine|March 27, 2023
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infectionsSelena Mimmi, Anna Maria Zimbo, Salvatore Rotundo, et al.
AIDS (London, England)|November 27, 2014
Impact of body weight on virological and immunological responses to efavirenz-containing regimens in HIV-infected, treatment-naive adultsCatia Marzolini, Caroline Sabin, François Raffi, et al.
BMC Infectious Diseases|September 20, 2014
Present, old and future strategies for anti-HCV treatment in patients infected by genotype-1: estimation of the drug costs in the Calabria Region in the era of the directly acting antiviralsAlessio Strazzulla, Chiara Costa, Vincenzo Pisani, et al.
Pageof 27

Showing results (201-210 of 263) with videos related to

Sort By:
Pageof 27
Mediterranean Journal of Hematology and Infectious Diseases|November 7, 2015
Demographical, Viro-Immunological, Clinical and Therapeutical Characteristics of HIV-Infected Patients in an "Epidemiologically Unexplored" Region of Italy (Calabria Region): the CalabrHIV CohortMaria Concetta Postorino, Filippo Luciani, Carmelo Mangano, et al.
AIDS Reviews|November 24, 2005
Antiretroviral therapy in chronic liver disease: focus on HIV/HCV coinfection--statements of the First Italian Consensus WorkshopGiampiero Carosi, Massimo Puoti, Giovanni Antonucci, et al.
Plos One|April 25, 2013
Clinical evaluation of Rega 8: an updated genotypic interpretation system that significantly predicts HIV-therapy responseJurgen Vercauteren, Gertjan Beheydt, Mattia Prosperi, et al.
Open Forum Infectious Diseases|July 28, 2015
Two Distinct Hepatitis C Virus Genotype 1a Clades Have Different Geographical Distribution and Association With Natural Resistance to NS3 Protease InhibitorsAndrea De Luca, Simona Di Giambenedetto, Alessandra Lo Presti, et al.
BMC Infectious Diseases|November 14, 2013
Superinfection with drug-resistant HIV is rare and does not contribute substantially to therapy failure in a large European cohortIstván Bartha, Matthias Assel, Peter M A Sloot, et al.
BMC Evolutionary Biology|March 9, 2017
Implications of hepatitis C virus subtype 1a migration patterns for virus genetic sequencing policies in ItalyLize Cuypers, Bram Vrancken, Lavinia Fabeni, et al.
Communications Medicine|November 19, 2025
Third-generation Cephalosporin resistance in Sub-Saharan Africa: a systematic review and meta-analysisGiacomo Guido, Luisa Frallonardo, Muhammad Asaduzzaman, et al.
Clinical Chemistry and Laboratory Medicine|March 27, 2023
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infectionsSelena Mimmi, Anna Maria Zimbo, Salvatore Rotundo, et al.
AIDS (London, England)|November 27, 2014
Impact of body weight on virological and immunological responses to efavirenz-containing regimens in HIV-infected, treatment-naive adultsCatia Marzolini, Caroline Sabin, François Raffi, et al.
BMC Infectious Diseases|September 20, 2014
Present, old and future strategies for anti-HCV treatment in patients infected by genotype-1: estimation of the drug costs in the Calabria Region in the era of the directly acting antiviralsAlessio Strazzulla, Chiara Costa, Vincenzo Pisani, et al.
Pageof 27